September 11, 2020
Today, California approved a new voluntary pilot program that uses Apple and Google smartphone technology to help rapidly control COVID-19 outbreaks. The program will launch on the campus of UC San Diego for any students and employees who opt in.
February 22, 2016
Ten teams of innovative students at UC San Diego have been awarded proof-of-concept funding to validate the product concepts behind their innovative projects.
December 5, 2023
UC San Diego scientists’ debut “reverse metabolomics,” a groundbreaking approach to advancing microbiome research. They use the technique to discover hundreds of new human molecules, and a new biomarker and therapeutic target for inflammatory bowel disease
December 3, 2018
Following the FDA’s approval of chimeric antigen receptor (CAR) T-cell therapies for the treatment of certain types of non-Hodgkin lymphomas, UC San Diego Health was the first medical center in San Diego to be certified to offer this type of immunotherapy outside of a clinical trial.
November 7, 2019
…and the School of Medicine, are using major Santa Ana wind-driven wildfires from 2003 and 2008 to trace the effects of fine-particle pollution and their spatio-temporal evolution. “Most studies looking at health effects of wildfires offer global estimates for a wildfire event and/or region,” said Aguilera. “We are looking at…
February 7, 2020
The Protein Data Bank archive has released a new Coronavirus protease structure following the recent coronavirus outbreak, an ongoing viral epidemic primarily affecting mainland China that now threatens to spread to other parts of the world.
July 7, 2022
UC San Diego researchers describe a new method to identify all of the unidentified molecules derived from food, providing a direct way to link molecules in diet to health outcomes.
April 19, 2023
Khristiane “Frances” Reyes credits a trip to the Philippines and a multidisciplinary team at UC San Diego Health for saving his life.
September 15, 2020
UC San Diego Health is the first hospital on the West Coast to perform heart transplant surgery from a donor after circulatory death using a new portable organ care system. The investigational procedure could significantly decrease transplant waiting list times and improve patient outcomes.
August 5, 2016
Rubén Flores, Ph.D., is the Director of Commercialization in UC San Diego’s Office of Innovation and Commercialization. Announcing his appointment in March of this year, Vice Chancellor for Research Sandra Brown said that he exemplifies the high-achieving entrepreneurial spirit necessary for new discoveries and new solutions.
